Bolt Biotherapeutics, Inc.
Ticker: BOLT
| Insider | Title |
|---|---|
| Brian O'callaghan | Director |
| Capital Fund Viii, L.p. Vivo | 10% or greater ownership |
| Capital Surplus Fund Viii, L.p. Vivo | 10% or greater ownership |
| Capital Viii, Llc Vivo | 10% or greater ownership |
| David Dornan | Chief Scientific Officer |
| Edgar Engleman | Director |
| Edith A. Perez | Chief Medical Officer |
| Frank D. Lee | Director |
| Grant Yonehiro | Chief Operating Officer |
| Holdings A/s Novo | 10% or greater ownership |
| Jakob Dupont | Director |
| James Healy | Director |
| Kathleen Laporte | Director |
| Laura Berner | Director |
| Mahendra Shah | Director |
| Nicole Onetto | Director |
| Opportunity Fund Holdings, L.p. Vivo | 10% or greater ownership |
| Opportunity, Llc Vivo | 10% or greater ownership |
| Panda Fund, L.p. Vivo | 10% or greater ownership |
| Panda, Llc Vivo | 10% or greater ownership |
| Randall C Schatzman | Chief Executive Officer, Director |
| Richard A Md Miller | Director |
| Sarah Nemec | VP, Finance and PAO |
| William P. Quinn | President, CEO and CFO, Director |